Combination treatment effects of BRAF (B-RAF proto-oncogene, serine/threonine kinase) inhibitors and HSP90 (heat shock protein 90) inhibitors in BRAF-mutated colorectal cancer cell lines
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Dissertation, 2024
- Schlagwort
-
Krebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Halle (Saale)
- (wer)
-
Universitäts- und Landesbibliothek Sachsen-Anhalt
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.25673/116275
- URN
-
urn:nbn:de:gbv:3:4-1981185920-1182316
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Klose, Georg Heinrich
- Feller, Stephan Michael
- Friedrich, Karl-Heinz
- Stange, Daniel
- Universitäts- und Landesbibliothek Sachsen-Anhalt
Entstanden
- 2024
Ähnliche Objekte (12)
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Braf, Albin
Brautpaar Braf
Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Braf, Albin
Brautpaar Braf
Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy
Design and Synthesis of Hsp90 Inhibitors with B‐Raf and PDHK1 Multi‐Target Activity
Targeting CDK 2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing
Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
Braf, Albin
Brautpaar Braf
Granulomatous Reactions from Tattoos Following BRAF Inhibitor Therapy